Welcome to our dedicated page for ORSN news (Ticker: ORSN), a resource for investors and traders seeking the latest updates and insights on ORSN stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ORSN's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ORSN's position in the market.
Orisun Acquisition Corp. (NASDAQ: ORSN, ORSNU) has secured a $53 million backstop investment commitment from 14 investors, including tech leaders, as they prepare for a merger with Ucommune. This agreement allows investors to acquire Orisun's common stock or purchase shares in a private placement at $10.10 per share upon closing, expected in Q4 2020. Ucommune operates as China's largest agile office space manager, boasting 185 locations and 28,700 enterprise members as of June 2020, positioning them for significant growth post-merger.
Orisun Acquisition Corp. (NASDAQ: ORSN, ORSNU) has announced a definitive merger agreement with Ucommune Group Holdings Limited, China's largest agile office space manager. Founded in 2015, Ucommune serves over 700,000 members across 211 locations in Greater China and Singapore. The merger, expected to close with a pro forma value of approximately $769 million, allows Ucommune to enhance its asset-light operations and market presence. In 2019, Ucommune reported revenue of 1,179 million RMB, with an estimated growth to 2,100 million RMB by 2022.
